Next Article in Journal
Plasma-Based Measurements of Tumor Heterogeneity Correlate with Clinical Outcomes in Metastatic Colorectal Cancer
Previous Article in Journal
Limitations of Nerve Fiber Density as a Prognostic Marker in Predicting Oncological Outcomes in Hepatocellular Carcinoma
 
 
Article
Peer-Review Record

Template-Independent Poly(A)-Tail Decay and RNASEL as Potential Cellular Biomarkers for Prostate Cancer Development

Cancers 2022, 14(9), 2239; https://doi.org/10.3390/cancers14092239
by Gordana Kocić 1,*, Jovan Hadzi-Djokić 2, Andrej Veljković 1, Stefanos Roumeliotis 3, Ljubinka Janković-Veličković 4 and Andrija Šmelcerović 5
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Cancers 2022, 14(9), 2239; https://doi.org/10.3390/cancers14092239
Submission received: 7 March 2022 / Revised: 6 April 2022 / Accepted: 12 April 2022 / Published: 29 April 2022
(This article belongs to the Topic Prostate Cancer: Symptoms, Diagnosis & Treatment)

Round 1

Reviewer 1 Report

Data in table 1. do not make any sense regarding Gleason score and tumor stage.

Gleason score is usually expressed as 3+3, 3+4, 4+3, 4+4, 4+5 etc.

Tumor stage 2,27 , what does it mean?

Table 1. The age and the level of PSA, Gleason score and Tumor stage in investigated patients...
PC. 161
Investigated parameters X+SD
Age 68.27+ 3.45
(range 25–74 years)
tPSA (ng/mL) 15.84+8.77
Gleason score 6.76+0.59
Tumor stage 2.27+0.70

Author Response

Please find attached the reviewers answer and correction

Author Response File: Author Response.docx

Reviewer 2 Report

RNase L is a uniquely regulated endoribonuclease that requires 5'-triphosphorylated, 2',5'-linked oligoadenylates for its activity. RNase L functions in counteracting prostate cancer by virtue of its ability to degrade RNA, thus initiating a cellular stress response that leads to apoptosis. Intervening the role RNaseL in prostate cancer has been documented earlier. The author identified an increase of poly(A) deadenylase specific activity ranging from two to 247 ten times, followed by more than the twofold increase of its activity in adjacent carcinoma 248 tissue, compared to the control healthy tissue counterparts which are significant in this case. It will be worth calculating the sensitivity and specificity with respect to the above patient cohorts.

Author Response

Please find attached our answer and corrections.

Author Response File: Author Response.docx

Round 2

Reviewer 1 Report

Nicely corrected. 

Reviewer 2 Report

The author addressed the raised concern 

Back to TopTop